Transnasal Induction of Normothermia in Febrile Stroke Patients
Sponsor: CoolTech LLC
Listed as NCT03360656, this NA trial focuses on Fever and Metabolic Encephalopathy and remains completed. Sponsored by CoolTech LLC, it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
-
Jun 2022 — Jul 2023 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 7 earlier versions
-
Oct 2021 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jan 2020 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2020 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CoolTech LLC
For direct contact, visit the study record on ClinicalTrials.gov .